Published: 2022-07-14

The Effects of the COVID-19 Pandemic on Pre-School Age Children: A Retrospective Study

Fethiye Kılıçaslan, Büşra Bakırcı, Hamza Ayaydın, Meryem Özlem Kütük

(32-37)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.21002

Effectiveness of Selenium Supplement on Cognitive Function in Patients with Epilepsy

Mehdi Maghbooli, Rosa Davallou, Zahra Jourahmad, Sajjad Biglari

(38-41)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.21003

Relationship of Sleep Disturbances in Children with Depression / Anxiety Symptoms in Children and Their Parents During the Covid-19 Pandemic

Zehra Koyuncu, Mehmet Enes Gökler, Aslı Begüm Can Aydın, Feyza Adıyaman, Mahmut Cem Tarakçıoğlu, Muhammed Tayyib Kadak, Fırat Erdoğan, Meryem Seçen Yazıcı

(42-48)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.22013

The Effects of the COVID-19 Pandemic on Pre-School Age Children: A Retrospective Study

Fethiye Kılıçaslan, Büşra Bakırcı, Hamza Ayaydın, Meryem Özlem Kütük

(32-37)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.21002

Effectiveness of Selenium Supplement on Cognitive Function in Patients with Epilepsy

Mehdi Maghbooli, Rosa Davallou, Zahra Jourahmad, Sajjad Biglari

(38-41)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.21003

Relationship of Sleep Disturbances in Children with Depression / Anxiety Symptoms in Children and Their Parents During the Covid-19 Pandemic

Zehra Koyuncu, Mehmet Enes Gökler, Aslı Begüm Can Aydın, Feyza Adıyaman, Mahmut Cem Tarakçıoğlu, Muhammed Tayyib Kadak, Fırat Erdoğan, Meryem Seçen Yazıcı

(42-48)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.22013

Two Cases of Olfactory Reference Syndrome Treated with Risperidone

Balaswamy Reddy, Alessandra Nocera, Renato de Filippis, Soumitra Das

(49-51)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.22004

Two Cases of Olfactory Reference Syndrome Treated with Risperidone

Balaswamy Reddy, Alessandra Nocera, Renato de Filippis, Soumitra Das

(49-51)

DOI: https://doi.org/10.5152/NeuropsychiatricInvest.2022.22004